Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL6X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $197,462
Award facts
- Contract value 100% obligated
- $197,461.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $197,461.66 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 28, 2026, for the supply of NURTEC ODT 75 MG tablets in quantities of eight, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NURTEC ODT (rimegepant) is a calcitonin gene-related peptide receptor antagonist used for the acute treatment of migraine in adults, representing a specialized pharmaceutical supply need within the Defense Health Agency's medical supply chain.
This delivery order is a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a wide range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills such specialized medication requirements for military treatment facilities and other federal healthcare systems through this expansive contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FFL6X?
SPE2DR26FFL6X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FFL6X worth?
The government has obligated $197,462 on SPE2DR26FFL6X.
Is contract SPE2DR26FFL6X an order under another contract?
Yes. SPE2DR26FFL6X is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL6X competed?
The extent of competition for SPE2DR26FFL6X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award